Geriatric Population and Mobile Technology Fueling Growth in Chronic Disease Management Market: with an expected value of US$ 16.83 Billion by 2033 | Future Market Insights, Inc.

In the rapidly growing Chronic Disease Management Market, players are facing several challenges in delivering effective solutions to the rising prevalence of chronic illnesses such as diabetes and heart troubles. The market is bolstered by the increasing geriatric population and the high penetration of mobile technology in illness management, as highlighted by a recent study by Future Market Insights. The study further discusses the key driving factors of the global Chronic Disease Management Market.

| Source: Future Market Insights Global and Consulting Pvt. Ltd. Future Market Insights Global and Consulting Pvt. Ltd.

NEWARK, Del, Aug. 02, 2023 (GLOBE NEWSWIRE) -- The Chronic Disease Management Market has witnessed significant growth in recent years, driven by the escalating prevalence of chronic diseases worldwide. As the global population ages and lifestyle-related factors become more prominent, chronic conditions such as diabetes, cardiovascular diseases, cancer, and respiratory disorders continue to surge. Addressing this challenge, the market for chronic disease management solutions has evolved to enhance patient outcomes and reduce the burden on healthcare systems.

The Chronic Disease Management Market is anticipated to thrive at a steady CAGR of 13.4% between 2023 and 2033. The market is expected to have a market share of US$ 16.83 Billion by 2033 while it is likely to be valued at US$ 4.77 Billion in 2023.

Key Driving Factors of Chronic Disease Management Market:

  • The increasing lifestyle-based diseases along with the advanced healthcare infrastructure and online management-based solutions are expected to flourish the market growth. Furthermore, the increasing per capita income and independent patients are some other factors positively affecting the market dynamics.
  • The idle lifestyle and poor eating habits have pushed long-term diseases like diabetes, high blood pressure, etc. to flourish the market growth across the region. Further, coordinated care across teams, enhanced overall care, high 24/7 access to vendors, and frequent phone check-ins are some of the progressive elements that propel the market’s success.
  • Better management improves access to care and satisfaction while delivering quality healthcare and integrating smart technologies like artificial intelligence, machine learning, and cloud computing. Advanced disease management platforms come with sensory technology for symptom detection.
  • The significant task of the chronic diseases management solution is to rectify symptoms and deliver suitable treatment, and diagnostics while helping the patients with advanced treatment. Also, the recurring revenue for providers and better patient engagement like this is helping the market expand its boundaries.

Discover the key insights and growth drivers in the rapidly expanding Chronic Disease Management Market. Get a comprehensive understanding of the market drivers and opportunities. Download the sample report today! https://www.futuremarketinsights.com/reports/sample/rep-gb-5370

Key Takeaways from Chronic Disease Management Market:

  1. The United States market leads North America’s chronic disease management market in terms of market share in North America. The United States held a market share of 38.4% in 2022. The factors attributed to the growth are advanced healthcare, and a high prevalence of chronic diseases like diabetes, lung cancer, stroke, and heart disease. The North America region held a market share of 44.1% in 2022
  2. Germany’s chronic disease management market held a healthy market share of 5.9% in 2022. The market growth is caused by the government’s efforts for better public health and the rising penetration of technology in healthcare. The Europe region held a market share of 29.7% in 2022.
  3. India’s market thrives at a steady CAGR of 15.9% between 2023 and 2033. The growth is attributed to the high economic activities, flourishing healthcare sector along with high-end research and development in the field.
  4. China's chronic disease management market thrives at a CAGR of 19.4% between 2023 and 2033.
  5. Based on delivery type, the on-premise segment held the leading market share of 54.3% in 2022.
  6. Based on end users, the provider’s segment leads as it held a market share of 58.8% in 2022

Competitive Scenario of Chronic Disease Management Market:

The key suppliers focus on easy deployment, user-friendly functionality, and effective results. The competitors merge, acquire, and partner with other companies to increase their supply chain and distribution channel.

  1. TriZetto Corporation
  2. IBM
  3. Pegasystems Inc.
  4. EXL Healthcare
  5. AxisPoint Health
  6. Wellcentive, Inc.
  7. Medecision, Inc.
  8. i2i Systems, Inc.
  9. HealthSmart Holdings, Inc.
  10. Allscripts Healthcare Solutions, Inc.
  11. ZeOmega Inc.
  12. Epic Corporation Inc.
  13. Harmony Information Systems, Inc.

To Stay Ahead In This Competitive Landscape And Gain A Comprehensive Understanding Of Market Dynamics, Challenges, And Growth Opportunities, Speak To Our Research Expert Today! https://www.futuremarketinsights.com/ask-question/rep-gb-5370

Recent Market Developments of Chronic Disease Management Market:

  • Pegasystems Inc., Had previously tied with MCG Health for the integration of industry-leading chronic care pega care management application. Now, the company has a data-based patient care system with improved outcomes and an action-based treatment plan.
  • EXL Healthcare has added its integrated and analytic-driven chronic care management that driveshigh-qualityy and cost-friendly benefits.
  • Increased Telemedicine Adoption: The COVID-19 pandemic has accelerated the adoption of telemedicine and virtual care solutions for managing chronic diseases, providing convenient access to healthcare services.
  • Wearable Health Tech Advancements: Technological advancements in wearable health devices have enabled more accurate and continuous monitoring of chronic conditions, empowering patients to take an active role in managing their health.
  • AI-Driven Predictive Analytics: The integration of AI and predictive analytics in chronic disease management platforms allows for early detection of disease progression and personalized treatment plans.
  • Focus on Remote Patient Monitoring: Remote patient monitoring solutions are gaining popularity, enabling healthcare providers to remotely track patients' health metrics and intervene proactively when necessary.
  • Personalized Nutrition and Lifestyle Interventions: Chronic disease management programs are increasingly incorporating personalized nutrition and lifestyle interventions to improve patient outcomes and overall well-being.

Click Here To Purchase Our Comprehensive Market Report And Gain A Competitive Edge In The Dynamic Landscape Of Chronic Disease Management Market! https://www.futuremarketinsights.com/checkout/5370

Key Market Segments Covered in the Chronic Disease Management Industry Research

Chronic Disease Management Market by Service Type:

  • Consulting Services
  • Implementation Services
  • Educational Services
  • Other

By Delivery Mode:

  • On-premise
  • Web-based
  • Cloud-based

By End User:

  • Providers
  • Payers

Key Regions Covered:

  • North America
    • The United States
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • The United Kingdom
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Japan
  • Asia Pacific Excluding Japan
    • China
    • India
    • Malaysia
    • Singapore
    • Australia
    • Rest of Asia Pacific Excluding Japan (APEJ)
  • The Middle East and Africa
    • GCC Countries
    • Israel
    • South Africa
    • The Middle East and Africa (MEA)

To Save Up To 30%, You Can Tailor Your Report By Choosing Particular Countries Or Regions! https://www.futuremarketinsights.com/customization-available/rep-gb-5370

Explore Wide-ranging Coverage of FMI’s Healthcare Landscape:

Chronic Granulomatous Disease (CGD) Management Market Size: The global chronic Granulomatous disease (CGD) management market is expected to garner a market value of US$ 1.31 Billion in 2023 and is expected to accumulate a market value of US$ 2.11 Billion by registering a CAGR of 4.9% in the forecast period 2023 to 2033.

Chronic Respiratory Diseases Treatment Market Share: Chronic respiratory diseases that affect mainly the airways and other structures of the lungs. Chronic respiratory diseases include chronic obstructive pulmonary disease, asthma, chronic sinusitis, occupational lung diseases, and pulmonary fibrosis, among others.

Late Stage Chronic Kidney Disease Therapeutics Market Growth: The global demand for late-stage chronic kidney disease therapeutics was valued at around US$ 4.7 Billion in 2019. However, with the rising prevalence of chronic kidney disease across the globe, the overall late-stage kidney disease therapeutics market is anticipated to surpass US$ 11.1 Billion in 2027 and is forecast to grow at a prolific CAGR of around 11.6% throughout the forecast period (2022 –2032)

Chronic Obstructive Pulmonary Disease (COPD) Market Trend: The global Chronic Obstructive Pulmonary Disease (COPD) market size is expected to be valued at US$ 21.58 Billion in 2023.

Chronic Pulmonary Hypertension Treatment Market Forecast: The global chronic pulmonary hypertension treatment market is expected to garner a market value of US$ 7 billion in 2023 and is expected to accumulate a market value of US$ 11.4 billion by registering a CAGR of 5% in the forecast period 2023 to 2033.

Chronic Hepatitis B Virus Testing Market Analysis: The global Chronic Hepatitis B Virus Testing market garnered a market value of US$ 919 Million in 2023 and is expected to accumulate a market value of US$ 1790 Million by registering a CAGR of 6.9% in the forecast period 2023 to 2033.

Chronic Lymphocytic Leukemia Market Sales: Chronic lymphocytic leukemia (CLL) is a blood and bone marrow disease that usually gets adverse slowly. It is one of the most common types of leukemia in adults.

Chronic Respiratory Diseases Treatment Market Outlook: Chronic respiratory diseases that affect mainly the airways and other structures of the lungs. Chronic respiratory diseases include chronic obstructive pulmonary disease, asthma, chronic sinusitis, occupational lung diseases, and pulmonary fibrosis, among others.

Autoimmune Disease Therapeutics Market Volume: The global autoimmune disease therapeutics market is likely to be valued at US$ 71,466.47 million in 2023 and is predicted to secure a moderate-paced CAGR of 5.6% during the forecast period. The market is expected to grow at a value of US$ 123,507.30 million by 2033.

Infectious Disease Diagnostics Market Application: In 2022, the infectious disease diagnostics market is anticipated to be worth US$ 1.47 billion in terms of revenue. The market is projected to expand at a CAGR of 7% to reach a size of US$ 3.48 billion by 2032.

About Future Market Insights (FMI):

Future Market Insights, Inc. (ESOMAR certified, Stevie Award - recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10 years.

Contact Us:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
LinkedIn | Twitter | Blogs | YouTube
For Sales Enquiries: sales@futuremarketinsights.com


Tags

Chronic Disease Management Chronic Disease Industry

Related Links